Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Ovarian Neoplasms 26Small Cell Lung Carcinoma 22Neuroblastoma 12Fallopian Tube Neoplasms 12Uterine Cervical Neoplasms 8Carcinoma, Ovarian Epithelial 8Lung Neoplasms 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 4Leukemia, Myeloid, Acute 3Ganglioneuroblastoma 3Brain Neoplasms 3Sarcoma 2Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Carcinoma, Neuroendocrine 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdoid Tumor 1Retinoblastoma 1Retinal Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Topotecan × Clear all
NCT00437073 2015-10-15

Brain Metastases In ErbB2-Positive Breast Cancer

GlaxoSmithKline

Phase 2 Terminated
22 enrolled 8 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡